Altimmune, Inc. - 10-Q Filing
Altimmune, Inc. reports quarterly results for the period ended September 30, 2026, featuring significant equity activity and secured debt tranches.
Tickers: $ALT
Altimmune, Inc. reports quarterly results for the period ended September 30, 2026, featuring significant equity activity and secured debt tranches.
Tickers: $ALT